NCT02580799View on ClinicalTrials.gov

Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Breast Cancer
Trial Locations (5)

34093

Istanbul University Istanbul Medical Faculty, Istanbul

34098

Istanbul University Cerrahpasa Medical Faculty, Istanbul

35100

Ege University Medical Faculty, Izmir

35210

Dokuz Eylul University Medical Faculty, Izmir

06230

Ankara University Medical Faculty, Ankara

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02580799 - Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples | Biotech Hunter | Biotech Hunter